检索结果-南通市图书馆

Glucose intolerance and diabetes mellitus in ulcerative colitis: Pathogenetic and therapeutic implications

World Journal of Gastroenterology 2014年第13期20卷 3507-3515页

作者： Giovanni Maconi federica furfaro Roberta Sciurti Cristina Bezzio Sandro Ardizzone Roberto de Franchis Gastroenterology Unit Department of Biomedical and Clinical Sciences"Luigi Sacco" University Hospital20157 MilanoItaly

Diabetes mellitus is one of the most frequent co-morbidities of ulcerative colitis *** epidemiological association of these diseases suggested a genetic sharing and has challenged gene *** co-morbidity in ulcerative colitis has also relevant clinical and therapeutic implications,with potential clinical impact on the follow up and outcome of *** diseases share specific complications,such as neuropathy,hepatic steatosis,osteoporosis and venous *** is still unknown whether the coexistence of these diseases may increase their *** and hyperglycaemia represent relevant risk factors for postoperative complications and pouch failure in ulcerative *** treatment of ulcerative colitis in patients with diabetes mellitus may be particularly *** are the treatment of choice of active ulcerative *** use may be associated with the onset of glucose intolerance and diabetes,with difficult control of glucose levels andwith complications in diabetic *** and genetic evidences about diabetes co-morbidity in ulcerative colitis patients and shared complications and treatment of patients with these diseases have been discussed in the present review.

关键词： Diabetes mellitus Ulcerative colitis Diabetes complications Inflammatory bowel diseases Glucose intolerance Medical therapy Corticosteroids

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Viral infections in inflammatory bowel disease:Tips and tricks for correct management

引用

World Journal of Gastroenterology 2021年第27期27卷 4276-4297页

作者： Vincenzo Craviotto federica furfaro Laura Loy Alessandra Zilli Laurent Peyrin-Biroulet Gionata Fiorino Silvio Danese Mariangela Allocca Humanitas Clinical and Research Center IRCCSRozzano 20089MilanoItaly Department of Hepato-Gastroenterology and Inserm U954 University Hospital of NancyLorraine UniversityNancy 54511France Department of Biomedical Sciences Humanitas UniversityPieve Emanuele 20090MilanoItaly

Over the past decades,the treatment of inflammatory bowel diseases(IBD)has become more targeted,anticipating the use of immune-modifying therapies at an earlier *** top-down approach has been correlated with favorable short and long-term outcomes,but it has also brought with it concerns regarding potential infectious *** large IBD population treated with immunemodifying therapies,especially if combined,has an increased risk of severe infections,including opportunistic infections that are sustained by viral,bacterial,parasitic,and fungal *** infections have emerged as a focal safety concern in patients with IBD,representing a challenge for the clinician:they are often difficult to diagnose and are associated with significant morbidity and *** first step is to improve effective preventive strategies,such as applying vaccination protocols,adopt adequate prophylaxis and educate patients about potential risk *** viral infections in immunosuppressed patients may present atypical signs and symptoms,the challenges for the gastroenterologist are to suspect,recognize and diagnose such *** treatment of common viral infections allows us to minimize their impact on disease outcomes and patients’*** practical review supports this standard of care to improve knowledge in this subject area.

关键词： Inflammatory bowel diseases Viral infections Opportunistic infections Standard of care Crohn’s disease Ulcerative colitis

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Intestinal ischemic manifestations of SARS-CoV-2:Results from the ABDOCOVID multicentre study

引用

World Journal of Gastroenterology 2021年第32期27卷 5448-5459页

作者： Lorenzo Norsa Pietro Andrea Bonaffini Maja Caldato Cristiana Bonifacio Aurelio Sonzogni Amedeo Indriolo Clarissa Valle federica furfaro Alice Bonanomi Paolo NiccolòFranco Mauro Gori Veronica Smania Lucia Scaramella Laura Forzenigo Maurizio Vecchi Monica Solbiati Giorgio Costantino Silvio Danese Lorenzo D'Antiga Sandro Sironi Luca Elli Department of Pediatric Gastroenterology Hepatology and Transplantation ASST Papa Giovanni XXIIIBergamo 24127Italy Department of Radiology Papa Giovanni XXIII Bergamo University of Milano-BicoccaMilan 20126Italy Fondazione IRCCS Ca’Granda Department of Emergency MedicineOspedale Maggiore PoliclinicoMilano 20122Italy Department of Radiology Humanitas Clinical and Research CenterIRCCSRozzano 20089Italy Department of Pathology ASST Papa Giovanni XXIIIBergamo 24127Italy Department of Gastroenterology and Endoscopy ASST Papa Giovanni XXIIIBergamo 24127Italy IBD Center Humanitas Clinical and Research Center IRCCSHumanitas UniversityRozzano 20089Italy Post-Graduate School of Diagnostic Radiology University of Milano-BicoccaMilano 20126Italy Cardiovascular Department ASST Papa Giovanni XXIIIBergamo 24127Italy Department of Gastroenterology and Endoscopy Fondazione IRCCS Ca'Granda Ospedale Maggiore PoliclinicoMilano 20122Italy Department of Pathophysiology and Transplantation University of MilanMilano 20122Italy Department of Radiology Fondazione IRCCS Ca'Granda Ospedale Maggiore PoliclinicoMilano 20122Italy Fondazione IRCCS Ca’Granda Department of Emergency MedicineOspedale Maggiore PoliclinicoDepartment of Clinical Sciences and Community HealthUniversity of MilanMilano 20122Italy

BACKGROUND Intestinal ischemia has been described in case reports of patients with severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)disease(coronavirus disease 19,COVID-19).AIM To define the clinical and histological,characteristics,as well as the outcome of ischemic gastrointestinal manifestations of SARS-CoV-2 *** A structured retrospective collection was promoted among three tertiary referral centres during the first wave of the pandemic in northern ***,radiological,endoscopic and histological data of patients hospitalized for COVID-19 between March 1st and May 30th were *** diagnosis was established by consecutive analysis of all abdominal computed tomography(CT)scans *** Among 2929 patients,21(0.7%)showed gastrointestinal ischemic manifestations either as presenting symptom or during *** CT showed bowel distention in 6 patients while signs of colitis/enteritis in *** patients presented thrombosis of main abdominal ***,when feasible,confirmed the diagnosis(6 patients).Surgical resection was necessary in 4/21 *** tissue examination showed distinctive features of endothelial inflammation in the small bowel and *** hospital stay was 9 d with a mortality rate of 39%.CONCLUSION Gastrointestinal ischemia represents a rare manifestation of COVID-19.A high index of suspicion should lead to investigate this complication by CT scan,in the attempt to reduce its high mortality *** shows atypical feature of ischemia with important endotheliitis,probably linked to thrombotic microangiopathies.

关键词： Coronavirus COVID-19 Ischemic colitis Small bowel ischemia Endothelial inflammation

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

The challenge of molecular selection in liver-limited metastatic colorectal cancer for surgical resection: a systematic review and meta-analysis in the context of current and future approaches

引用

Oncology Research 2024年第9期32卷 1407-1422页

作者： ROSSANA RONCATO JERRY POLESEL federica TOSI ELENA PERUZZI ERIKA BRUGUGNOLI CLAUDIA LAURIA PANTANO MARIA furfaro FILIPPO DI GIROLAMO ALESSANDRO NANI ARIANNA PANI NOEMI MILAN ELENA DE MATTIA ANDREA SARTORE-BIANCHI ERIKA CECCHIN Experimental and Clinical Pharmacology Unit Centro di Riferimento Oncologico di Aviano(CRO)IRCCSAviano33081Italy Department of Medicine(DMED) University of UdineUdine33100Italy Unit of Cancer Epidemiology Centro di Riferimento Oncologico di Aviano(CRO)IRCCSAviano33081Italy Department of Oncology and Hemato-Oncology Universitàdegli Studi di MilanoMilan20122Italy Department of Hematology Oncologyand Molecular MedicineGrande Ospedale Metropolitano NiguardaMilan20122Italy Oncology Pharmacy Unit IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino AmadoriMeldola47014Italy Pharmacy Unit Fondazione IRCCS Istituto Tumori di MilanoMilan20122Italy Department of Pharmacy Ca’Foncello Treviso Regional HospitalPiazzale Ospedale 1Treviso31100Italy Department of Medical Surgical and Health Sciences University of TriesteTrieste34127Italy Hospital Pharmacy Cattinara HospitalAzienda Sanitaria Universitaria Giuliano IsontinaTrieste34148Italy Department of Oncology and Onco-Hematology Postgraduate School of Clinical Pharmacology and ToxicologyUniversity of MilanMilan20122Italy

Objectives:Treatment of metastatic colorectal cancer(mCRC)includes resection of liver metastases(LM),however,no validated biomarker identifies patients most likely to benefit from this *** meta-analysis aimed to assess the impact of the most relevant molecular alterations in cancer-related genes of CRC(i.e.,RAS,BRAF,SMAD4,PIK3CA)as prognostic markers of survival and disease recurrence in patients with mCRC surgically treated by LM ***:A systematic literature review was performed to identify studies reporting data regarding survival and/or recurrence in patients that underwent complete liver resection for CRC LM,stratified according to RAS,BRAF,PIK3CA,and SMAD4 mutational *** ratios(HRs)from multivariate analyses were pooled in the meta-analysis and various adjustment strategies for confounding factors were *** search was conducted in numerous databases,including MEDLINE(PubMed),Embase,Cumulative Index to Nursing and Allied Health Literature(CINAHL)(EBSCO host),and WHO Global Index Medicus,through March 18th,***-analyses,editorials,letters to the editor,case reports,studies on other primary cancers,studies with primary metastatic sites other than the liver,studies lacking specific oncological outcome variables or genetic data,non-English language studies,and studies omitting residual disease data from liver metastasectomy were *** remaining 47 studies were summarized in a descriptive table which outlines the key characteristics of each study and final results were graphically ***:RAS mutation status was negatively associated with overall survival(OS)(HR,1.68;95%CI,1.54–1.84)and recurrence free survival(RFS)(HR,1.46;95%CI,1.33–1.61).A negative association was also found for BRAF regarding OS(HR,2.64;95%CI,2.15–3.24)and RFS(HR,1.89;95%CI,1.32–2.73)and SMAD4 regarding OS(HR,1.93;95%CI,1.56–2.38)and RFS(HR,1.95;95%CI,1.31–2.91).For PIK3CA only three studies were eligible and no significant associati

关键词： Metastasectomy Liver metastases RAS BRAF SMAD4 PIK3CA Colorectal

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：